Showing results (61-70 of 76) with videos related to
Sort By:
Pageof 8
Journal of Thoracic Disease|December 7, 2020
Time to surgery in thoracic cancers and prioritization during COVID-19: a systematic reviewScott C Fligor, Savas T Tsikis, Sophie Wang, et al.Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|July 2, 2020
Gastrointestinal Malignancies and the COVID-19 Pandemic: Evidence-Based Triage to SurgeryScott C Fligor, Sophie Wang, Benjamin G Allar, et al.Neuro-Oncology|July 2, 2013
Cooperativity between MAPK and PI3K signaling activation is required for glioblastoma pathogenesisMark Vitucci, Natalie O Karpinich, Ryan E Bash, et al.Journal of Immunology (Baltimore, Md. : 1950)|August 25, 2023
CSF-1R+ Macrophages Control the Gut Microbiome-Enhanced Liver Invariant NKT Function through IL-18Chi Ma, Justin McCallen, John C McVey, et al.Clinical and Translational Science|April 22, 2025
Phenoconversion of CYP3A4, CYP2C19 and CYP2D6 in Pediatrics, Adolescents and Young Adults With Lymphoma: Rationale and Design of the PEGASUS StudyRachel Conyers, Tayla Stenta, Andrew A Somogyi, et al.Research Square|May 19, 2025
Integrating soft robotics and computational models to study left atrial hemodynamics and device testing in sinus rhythm and atrial fibrillationEllen Roche, Manisha Singh, Keegan Mendez, et al.Cancer|January 9, 2019
Distinct genome-wide methylation patterns in sporadic and hereditary nonfunctioning pancreatic neuroendocrine tumorsAmit Tirosh, Sanjit Mukherjee, Justin Lack, et al.Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|June 9, 2021
Cerebrospinal fluid hemoglobin drives subarachnoid hemorrhage-related secondary brain injuryKevin Akeret, Raphael M Buzzi, Christian A Schaer, et al.Bioorganic & Medicinal Chemistry Letters|May 15, 2014
Solving time-dependent CYP3A4 inhibition for a series of indole-phenylacetic acid dual antagonists of the PGD(2) receptors CRTH2 and DPMichael G Johnson, Jim Jiwen Liu, An-Rong Li, et al.The Oncologist|March 11, 2022
A Phase II Study of Pembrolizumab in Combination with Capecitabine and Oxaliplatin with Molecular Profiling in Patients with Advanced Biliary Tract CarcinomaCecilia Monge, Erica C Pehrsson, Changqing Xie, et al.Pageof 8